Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shenzhen Hepalink Pharmaceutical Group

Shenzhen Hepalink Pharmaceutical Group
1998 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
002399 STOCK SYMBOL
9 INVESTMENTS
$2.40 SHARE PRICE (As of Wednesday Closing)
Description

Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in the supply of heparin sodium drugs. The company distributes its products both in the domestic and overseas markets. Its projects portfolio includes National Bio-High Technology Industrialization Demonstration, the National Torch Program, and the National Key Technology Innovation Project.

Formerly Known As
Shenzhen Hepalink Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Stock Exchange
SHE
Primary Office
  • 21 Langshan Road
  • Songpingshan
  • Shenzhen, Nanshan District 518057
  • China

+86 0755 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shenzhen Hepalink Pharmaceutical Group’s full profile, request a free trial.

Shenzhen Hepalink Pharmaceutical Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.12 - $4.22 $2.99B $2.43 $0.10 6.19M 1.25B

Shenzhen Hepalink Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 3,725,015 4,443,331 2,813,659 2,893,560
Revenue 672,162 727,855 420,749 339,437
EBITDA 177,410 162,949 56,785 83,758
Net Income 121,663 93,147 29,101 59,586
Total Assets 2,078,520 1,985,039 2,162,630 1,859,729
Total Debt 694,786 644,125 537,876 368,400
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shenzhen Hepalink Pharmaceutical Group Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 00 27-Feb-2018 00000 0000000 Other Healthcare Services 00 00
00000000000 04-Dec-2017 0000 0000 Biotechnology
00000000000 20-Jun-2017 000000 0000000000 00.000 Biotechnology
00000 24-Nov-2016 00000 00000 00 00000 Drug Discovery
OncoVent 16-Mar-2016 Joint Venture 00.00 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Shenzhen Hepalink Pharmaceutical Group Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 01-Aug-2015 00000 00000 00 00.000 Completed
  • 00000000 00000000
To view this company’s complete exits history, request access »

Shenzhen Hepalink Pharmaceutical Group Subsidiaries (1)

Company Name Industry Location Founded
00000000 000 Pharmaceuticals 0000
To view this company’s complete subsidiary history, request access »

Shenzhen Hepalink Pharmaceutical Group Executive Team (4)

Name Title Board
Seat
Contact
Info
Li Li Co-Founder, President & Chairman of Board
Zhang Bin Chief Financial Officer
Li Tan Co-Founder, Director & Deputy General Manager
Bu Haihua Vice President, Board Member & Board Secretary

Shenzhen Hepalink Pharmaceutical Group Board Members (6)

Name Representing Role Since Contact
Info
00 000000 Shenzhen Hepalink Pharmaceutical Group Vice President, Board Member & Board Secretary 000 0000
00 00 Shenzhen Hepalink Pharmaceutical Group Co-Founder, President & Chairman of Board 000 0000
00 000 Shenzhen Hepalink Pharmaceutical Group Co-Founder, Director & Deputy General Manager 000 0000
00000 00000000 Shenzhen Hepalink Pharmaceutical Group Independent Director 000 0000
00000 00000 Shenzhen Hepalink Pharmaceutical Group Chairman of the Supervisory Board 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »